Anthony M. Manning, Ph.D.
Board Member
Monte Rosa Therapeutics, Inc. (GLUE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Anthony M. Manning, Ph.D.
Anthony M. Manning, Ph.D. is recorded as Board Member at Monte Rosa Therapeutics, Inc. (GLUE). Monte Rosa Therapeutics, Inc. reported in an 8-K filed July 26, 2023 that Anthony M. Manning, Ph.D. was appointed Class II director, effective July 25, 2023.
“On July 25, 2023, upon the recommendation of the Compensation, Nomination, and Corporate Governance Committee of the Board of Directors (the "Board") of Monte Rosa Therapeutics, Inc. (the "Company"), the Board appointed Anthony M. Manning, Ph.D. to fill the newly created vacancy on the Board resulting from an increase in the size of the Board from eight (8) to nine (9) directors.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-07-25–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Monte Rosa Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Jennifer Champoux COO, Board Member
- Matthew Bowen Chief Accounting Officer
- Andrew Schiff Board Member
- Anthony Manning Board Member
- Chandra P. Leo Board Member
- Eric A. Hughes, M.D., Ph.D. Board Member
- Filip Janku Board Member
- Jan Skvarka, Ph.D., MBA Board Member
- Philip Nickson Board Member
- Sharon Townson Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.